Bank Of America Corp Seelos Therapeutics, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.66 - $1.22 $164 - $303	249 Added 6.35%	4,172 $5,000
Q1 2023 May 12, 2023	BUY	$0.59 - $1.04 $1,076 - $1,898	1,825 Added 86.99%	3,923 $2,000
Q4 2022 Feb 10, 2023	SELL	$0.66 - $259.46 $795 - $312,908	-1,206 Reduced 36.5%	2,098 $1,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $91,984 - $39.4 Million	-141,515 Reduced 97.72%	3,304 $3,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $179,595 - $327,497	-352,148 Reduced 70.86%	144,819 $98,000
Q1 2022 May 16, 2022	BUY	$0.84 - $1.71 $323,023 - $657,583	384,552 Added 342.08%	496,967 $416,000
Q4 2021 Feb 08, 2022	BUY	$1.59 - $2.38 $168,713 - $252,539	106,109 Added 1682.67%	112,415 $183,000
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $137,762 - $235,581	-81,516 Reduced 92.82%	6,306 $15,000
Q2 2021 Sep 13, 2021	BUY	$2.64 - $6.32 $231,850 - $555,035	87,822 New	87,822 $232,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.